• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】25437

【品名】4-methylphenylhydrosulfide

【CA登记号】106-45-6

【 分 子 式 】C7H8S

【 分 子 量 】124.20652

【元素组成】C 67.69% H 6.49% S 25.82%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(X)

The condensation of pyruvic aldehyde dimethyl acetal (I) with dimethylformamide dimethyl acetal (II) afforded ketoenamine (III), which was condensed with N-methyl guanidine (IV) to give pyrimidine (V). Acid hydrolysis of the acetal function of (V) yielded pyrimidine carboxaldehyde (VI), which was converted to the imine (VIII) by treatment with 1-Boc-4-aminopiperidine (VII). Isonitrile (XII) was prepared by condensation of 4-fluorobenzaldehyde (IX) with formamide and p-thiocresol (X), followed by dehydration of the resulting formamide (XI) by means of POCl3 and Et3N. Reaction of isonitrile (XII) with imine (VIII) in the presence of 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) produced imidazole (XIII). Finally, acid deprotection of the Boc group of (XIII) provided the title compound.

1 Adams, J.L.; Gallagher, T.F.; Garigipati, R.S.; Boehm, J.C.; Sisko, J.; Peng, Z.-Q.; Lee, J.C.-L. (SmithKline Beecham plc); Certain 1,4,5-tri-substd. imidazole cpds. useful as cytokine. EP 0809499; JP 1998512555; US 5593992; WO 9621452 .
2 Garigipati, R.S.; Adams, J.L.; Boehm, J.C. (SmithKline Beecham Corp.); Pyridyl imidazole cpds. and compsns.. US 5670527 .
3 Adams, J.L.; Boehm, J.C.; Imidazole cpds., use and process of making. US 5593991 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25433 1,1-dimethoxyacetone 6342-56-9 C5H10O3 详情 详情
(II) 11984 N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal 4637-24-5 C5H13NO2 详情 详情
(III) 25434 (E)-4-(dimethylamino)-1,1-dimethoxy-3-buten-2-one C8H15NO3 详情 详情
(IV) 28411 N-Methylguanidine 598-12-9 C2H7N3 详情 详情
(V) 28412 4-(dimethoxymethyl)-N-methyl-2-pyrimidinamine C8H13N3O2 详情 详情
(VI) 28413 2-(methylamino)-4-pyrimidinecarbaldehyde C6H7N3O 详情 详情
(VII) 28414 4-Amino-1-N-Boc-piperidine; tert-butyl 4-amino-1-piperidinecarboxylate; N-Boc-4-aminopiperidine 87120-72-7 C10H20N2O2 详情 详情
(VIII) 28415 tert-butyl 4-([(Z)-[2-(methylamino)-4-pyrimidinyl]methylidene]amino)-1-piperidinecarboxylate C16H25N5O2 详情 详情
(IX) 12337 4-fluorobenzaldehyde 459-57-4 C7H5FO 详情 详情
(X) 25437 4-methylphenylhydrosulfide 106-45-6 C7H8S 详情 详情
(XI) 25438 (4-fluorophenyl)[(4-methylphenyl)sulfanyl]methylformamide C15H14FNOS 详情 详情
(XII) 28416 4-Fluoro-alpha-(4-methylphenylsulfanyl)benzyl isocyanide C15H12FNS 详情 详情
(XIII) 28417 tert-butyl 4-[4-(4-fluorophenyl)-5-[2-(methylamino)-4-pyrimidinyl]-1H-imidazol-1-yl]-1-piperidinecarboxylate C24H29FN6O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VI)

Condensation of pyruvic aldehyde dimethyl acetal (I) with dimethylformamide dimehylacetal provided ketoenamine (II). This was cyclized with guanidine to afford aminopyrimidine (III). Then, hydrolysis of the dimethyl acetal of (III) with 3 M HCl yielded aldehyde (IV). 4-Fluorobenzaldehyde (V) was condensed with thiocresol (VI) and formamide in refluxing toluene to give 4-fluorophenyl-tolylthiomethyl formamide (VII), which was dehydrated to isocyanide (VIII) with POCl3 and Et3N at -30 C. Finally, imine (X), (obtained from pyrimidine aldehyde (IV) and 4-(3-aminopropyl)morpholine (IX)), was condensed with isocyanide (VIII) in the presence of 1,5,7-triazabicyclo[4.4.0]dec-5-ene to furnish the title imidazole.

1 Adams, J.L.; Boehm, J.C.; Kassis, S.; Gorycki, P.D.; Webb, E.F.; Hall, R.; Sorenson, M.; Lee, J.C.; Ayrton, A.; Griswold, D.E.; Gallagher, T.F.; Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorg Med Chem Lett 1998, 8, 22, 3111.
2 Adams, J.L.; Sheldrake, P.W.; Gallagher, T.F.; Garigipati, R.S.; Bender, P.E.; Boehm, J.C. (SmithKline Beecham plc); Tri-substd. imidazoles having multiple therapeutic properties. EP 0708768; WO 9502591 .
3 Garigipati, R.S.; Adams, J.L.; Boehm, J.C. (SmithKline Beecham Corp.); Pyridyl imidazole cpds. and compsns.. US 5670527 .
4 Adams, J.L.; Boehm, J.C.; Imidazole cpds., use and process of making. US 5593991 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25433 1,1-dimethoxyacetone 6342-56-9 C5H10O3 详情 详情
(II) 25434 (E)-4-(dimethylamino)-1,1-dimethoxy-3-buten-2-one C8H15NO3 详情 详情
(III) 25435 4-(dimethoxymethyl)-2-pyrimidinylamine C7H11N3O2 详情 详情
(IV) 25436 2-amino-4-pyrimidinecarbaldehyde C5H5N3O 详情 详情
(V) 12337 4-fluorobenzaldehyde 459-57-4 C7H5FO 详情 详情
(VI) 25437 4-methylphenylhydrosulfide 106-45-6 C7H8S 详情 详情
(VII) 25438 (4-fluorophenyl)[(4-methylphenyl)sulfanyl]methylformamide C15H14FNOS 详情 详情
(VIII) 25439 4-Fluoro-alpha-(4-methylphenylsulfanyl)benzyl isocyanide C15H12FNS 详情 详情
(IX) 25440 3-(4-morpholinyl)-1-propanamine 123-00-2 C7H16N2O 详情 详情
(X) 25441 4-([[3-(4-morpholinyl)propyl]imino]methyl)-2-pyrimidinamine C12H19N5O 详情 详情

合成路线3

该中间体在本合成路线中的序号:(III)

The formylation of 3,5-dichloropyridine (I) with methyl formate by means of lithium diisopropylamide (LDA) in THF gives 3,5-dichloropyridine-4-carbaldehyde (II), which is condensed with p-thiocresol (III) by means of K2CO3 in DMF (or t-BuOK in THF) yielding 3-chloro-5-(4-methylphenylsulfanyl)pyridine-4-carbaldehyde (IV). The cyclization of (IV) with methylthioglycolate (V) by means of K2CO3 in DMF affords 4-(4-methylphenylsulfanyl)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VI), which is finally treated with ammonia in methanol to obtain the target amide. Alternatively, The hydrolysis of the methyl ester (VI) with LiOH in hot isopropanol/water gives the corresponding free acid (VII), which is treated with oxalyl chloride in dichloromethane to obtain the acyl chloride (VIII). Finally, this compound is treated with NH4OH in THF/water to afford the target amide.

1 Boyd, S.A.; Stewart, A.O.; Bhatia, P.A.; et al.; Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells: Selective inhibition of ICAM-1 and E-selectin expression. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 73.
2 Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35535 3,5-dichloropyridine 2457-47-8 C5H3Cl2N 详情 详情
(II) 35536 3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde 136590-83-5 C6H3Cl2NO 详情 详情
(III) 25437 4-methylphenylhydrosulfide 106-45-6 C7H8S 详情 详情
(IV) 35537 3-chloro-5-[(4-methylphenyl)sulfanyl]isonicotinaldehyde C13H10ClNOS 详情 详情
(V) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VI) 35538 methyl 4-[(4-methylphenyl)sulfanyl]thieno[2,3-c]pyridine-2-carboxylate C16H13NO2S2 详情 详情
(VII) 35539 4-[(4-methylphenyl)sulfanyl]thieno[2,3-c]pyridine-2-carboxylic acid C15H11NO2S2 详情 详情
(VIII) 35540 4-[(4-methylphenyl)sulfanyl]thieno[2,3-c]pyridine-2-carbonyl chloride C15H10ClNOS2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(III)

The formylation of 3,5-dichloropyridine (I) with methyl formate by means of lithium diisopropylamide (LDA) in THF gives 3,5-dichloropyridine-4-carbaldehyde (II), which is condensed with p-thiocresol (III) by means of K2CO3 in DMF (or t-BuOK in THF) yielding 3-chloro-5-(4-methylphenylsulfanyl)pyridine-4-carbaldehyde (IV). The cyclization of (IV) with methyl thioglycolate (V) by means of K2CO3 in DMF affords 4-(4-methylphenylsulfanyl)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VI), which is finally condensed with 2,3-dihydroxypropylamine (VII) by means of NaH in DMF to obtain the target amide. Alternatively, The hydrolysis of the methyl ester (VI) with LiOH in hot isopropanol/water gives the corresponding free acid (VIII), which is treated with N-hydroxysuccinimide (IX) and DCC in dichloromethane to obtain the activated ester (X). Finally, this compound is treated with 2,3-dihydroxypropylamine (VII) in dioxane/methanol to afford the target amide. The activation of the acid (VIII) can also be performed with oxalyl chloride or EDC and HOBT.

1 Patel, S.A.; Staeger, M.A.; McCarty, C.M.; et al.; Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells: Selective inhibition of ICAM-1 and E-selectin expression. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 74.
2 Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35535 3,5-dichloropyridine 2457-47-8 C5H3Cl2N 详情 详情
(II) 35536 3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde 136590-83-5 C6H3Cl2NO 详情 详情
(III) 25437 4-methylphenylhydrosulfide 106-45-6 C7H8S 详情 详情
(IV) 35537 3-chloro-5-[(4-methylphenyl)sulfanyl]isonicotinaldehyde C13H10ClNOS 详情 详情
(V) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VI) 35538 methyl 4-[(4-methylphenyl)sulfanyl]thieno[2,3-c]pyridine-2-carboxylate C16H13NO2S2 详情 详情
(VII) 35539 4-[(4-methylphenyl)sulfanyl]thieno[2,3-c]pyridine-2-carboxylic acid C15H11NO2S2 详情 详情
(VIII) 35544 1-[([4-[(4-methylphenyl)sulfanyl]thieno[2,3-c]pyridin-2-yl]carbonyl)oxy]-2,5-pyrrolidinedione C19H14N2O4S2 详情 详情
Extended Information